Form Type: 4

SEC EDGAR Link
Acccession Number:0001104659-19-052641
Date:2019-09-30
Issuer: ABBOTT LABORATORIES (ABT)
Original Submission Date:

Reporting Person:

ALPERN ROBERT J
333 CEDAR STREET, C203 SHM
NEW HAVEN, CT 06520

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK EQUIVALENT UNITS 0.0 2019-09-30 deemed execution date A 94 (a) common shares 94 $0.00 7,647 direct
Footnotes
IDfootnote
f1 director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. the stock equivalent units earn the same return as if the fees were invested in abbott stock.
f2 balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Elevate your investments